Cyprotex US expands to new facility in Framingham, MA

  • Evotec SE announced today that Cyprotex US, LLC, the US site of Cyprotex a wholly owned subsidiary of Evotec, has completed its relocation from Watertown, MA to a new state-of-the-art facility in Framingham, MA, paving the way for significant further growth of its ADME-Tox services business for US-based customers.  Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter

    Du magst vielleicht auch